Molecular Determination of mirRNA-126 rs4636297, Phosphoinositide-3-Kinase Regulatory Subunit 1-Gene Variability rs7713645, rs706713 (Tyr73Tyr), rs3730089 (Met326Ile) and Their Association with Susceptibility to T2D.
diabetes mellitus
gene variations
genome wide association studies
miR126 rs4636297
microRNAs
phosphoinositide 3-kinase (PI3K)
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
29 Aug 2021
29 Aug 2021
Historique:
received:
11
08
2021
revised:
26
08
2021
accepted:
27
08
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Type 2 diabetes is a metabolic disease characterized by elevated blood sugar. It has serious complications and socioeconomic impact. The MicroRNAs are short single-stranded and non-coding RNA molecules. They regulate gene expression at the post-transcriptional levels. They are important for many physiological processes including metabolism, growth, and others. The phosphoinositide 3-kinase (PI3K) is important for insulin signaling and glucose uptake. The genome wide association studies have identified the association of certain loci with diseases including T2D. In this study we have examined the association of miR126 rs4636297 and Phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) gene Variations rs7713645, rs706713 (Tyr73Tyr), and rs3730089 (Met326Ile) with T2D using the amplification refractory mutation system PCR. Results indicated that there was a significant different (
Identifiants
pubmed: 34575638
pii: jpm11090861
doi: 10.3390/jpm11090861
pmc: PMC8469127
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Environ Res Public Health. 2018 Jan 05;15(1):
pubmed: 29304014
Nat Rev Endocrinol. 2020 May;16(5):276-283
pubmed: 32127696
J Epidemiol Glob Health. 2017 Dec;7(4):211-218
pubmed: 29110860
Oncotarget. 2017 Sep 28;8(56):95755-95763
pubmed: 29221163
Int J Mol Sci. 2018 Dec 18;19(12):
pubmed: 30567315
Mol Cell Endocrinol. 2017 Oct 15;454:77-86
pubmed: 28599789
J Biol Chem. 2017 Jul 14;292(28):11992-12006
pubmed: 28566288
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2124-8
pubmed: 11842213
Front Oncol. 2018 Dec 13;8:596
pubmed: 30619739
Front Endocrinol (Lausanne). 2017 Dec 05;8:343
pubmed: 29259578
Nat Commun. 2018 Jul 27;9(1):2941
pubmed: 30054458
J Hematol Oncol. 2013 Nov 22;6(1):88
pubmed: 24261963
Thromb J. 2012 Aug 28;10(1):16
pubmed: 22925274
Int J Mol Sci. 2014 Jun 12;15(6):10567-77
pubmed: 24927146
Diabetologia. 2006 Nov;49(11):2659-67
pubmed: 17016694
Sci Rep. 2017 Oct 27;7(1):14288
pubmed: 29079741
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2057-2070
pubmed: 30139042
Structure. 2011 Aug 10;19(8):1127-37
pubmed: 21827948
Med Sci (Basel). 2019 Jul 15;7(7):
pubmed: 31311124
J Biol Chem. 2011 Feb 25;286(8):6554-65
pubmed: 21138844
Sci Rep. 2020 Sep 8;10(1):14790
pubmed: 32901098
Int J Biol Sci. 2018 Aug 6;14(11):1483-1496
pubmed: 30263000
Diabetes Care. 2013 Jan;36 Suppl 1:S67-74
pubmed: 23264425
Curr Drug Metab. 2020;21(14):1152-1160
pubmed: 33115391
Biomed Res Int. 2013;2013:761617
pubmed: 24455723
Diab Vasc Dis Res. 2015 Mar;12(2):133-8
pubmed: 25616704
Nat Med. 2010 Apr;16(4):438-45
pubmed: 20348923
Adv Clin Exp Med. 2018 Jul;27(7):921-927
pubmed: 29893513
Cardiovasc Diabetol. 2019 Aug 30;18(1):113
pubmed: 31470851
J Pers Med. 2019 Nov 25;9(4):
pubmed: 31775219
Nat Med. 2017 Jul 11;23(7):804-814
pubmed: 28697184
Circ Res. 2010 Sep 17;107(6):810-7
pubmed: 20651284
J Pept Sci. 2013 Jun;19(6):362-9
pubmed: 23596087
Curr Diabetes Rev. 2016;12(4):359-368
pubmed: 26206092
Circ Res. 2016 May 27;118(11):1771-85
pubmed: 27230641
J Pers Med. 2019 Jun 06;9(2):
pubmed: 31174318
Anal Biochem. 2011 Feb 1;409(1):159-61
pubmed: 20950582
Curr Top Microbiol Immunol. 2010;346:87-114
pubmed: 20544340
PLoS One. 2012;7(11):e48621
pubmed: 23133645
ScientificWorldJournal. 2014;2014:565839
pubmed: 25114970
Acta Ophthalmol. 2021 Jun;99(4):e461-e469
pubmed: 33124182